Search research articles
Contact Us
Filters
Showing results (631-640 of 962) with videos related to
Page
of 97
Sort By:
Journal of Clinical Lipidology
|
July 3, 2024
Alirocumab and cardiovascular outcomes according to sex and lipoprotein(a) after acute coronary syndrome: a report from the ODYSSEY OUTCOMES study
Vera A Bittner, Gregory G Schwartz, Deepak L Bhatt, et al.
The Canadian Journal of Cardiology
|
February 26, 2024
Restrictive vs Liberal Blood Transfusions for Patients With Acute Myocardial Infarction and Anemia by Heart Failure Status: An RCT Subgroup Analysis
Gregory Ducrocq, Marine Cachanado, Tabassome Simon, et al.
JAMA Neurology
|
October 2, 2023
Underlying Causes of TIA and Minor Ischemic Stroke and Risk of Major Vascular Events
Philippa C Lavallée, Hugo Charles, Gregory W Albers, et al.
Circulation. Cardiovascular Interventions
|
July 13, 2019
Central Adjudication Identified Additional and Prognostically Important Myocardial Infarctions in Patients Undergoing Percutaneous Coronary Intervention
Christoph B Olivier, Deepak L Bhatt, Sergio Leonardi, et al.
Archives of Cardiovascular Diseases
|
September 12, 2022
Immediate versus staged complete myocardial revascularization in patients with ST-segment elevation myocardial infarction and multivessel disease: A post hoc analysis of the randomized FLOWER-MI trial
Victoria Tea, Jean-François Morelle, Romain Gallet, et al.
Circulation
|
August 26, 2023
Relating Lipoprotein(a) Concentrations to Cardiovascular Event Risk After Acute Coronary Syndrome: A Comparison of 3 Tests
Michael Szarek, Esther Reijnders, J Wouter Jukema, et al.
Journal of the American College of Cardiology
|
October 4, 2005
Circulating secretory phospholipase A2 activity predicts recurrent events in patients with severe acute coronary syndromes
Ziad Mallat, Ph Gabriel Steg, Joëlle Benessiano, et al.
The Canadian Journal of Cardiology
|
June 1, 2022
Alirocumab and Cardiovascular Outcomes in Patients With Previous Myocardial Infarction: Prespecified Subanalysis From ODYSSEY OUTCOMES
Chern-En Chiang, Gregory G Schwartz, Yedid Elbez, et al.
Journal of the American Heart Association
|
December 29, 2023
Cost-Effectiveness of Icosapent Ethyl in REDUCE-IT USA: Results From Patients Randomized in the United States
William S Weintraub, Deepak L Bhatt, Zugui Zhang, et al.
JACC. Cardiovascular Interventions
|
March 23, 2013
Effect of radial versus femoral access on radiation dose and the importance of procedural volume: a substudy of the multicenter randomized RIVAL trial
Sanjit S Jolly, John Cairns, Kari Niemela, et al.
Page
of 97
Search research articles
Search
Showing results (631-640 of 962) with videos related to
Sort By:
Page
of 97
Journal of Clinical Lipidology
|
July 3, 2024
Alirocumab and cardiovascular outcomes according to sex and lipoprotein(a) after acute coronary syndrome: a report from the ODYSSEY OUTCOMES study
Vera A Bittner, Gregory G Schwartz, Deepak L Bhatt, et al.
The Canadian Journal of Cardiology
|
February 26, 2024
Restrictive vs Liberal Blood Transfusions for Patients With Acute Myocardial Infarction and Anemia by Heart Failure Status: An RCT Subgroup Analysis
Gregory Ducrocq, Marine Cachanado, Tabassome Simon, et al.
JAMA Neurology
|
October 2, 2023
Underlying Causes of TIA and Minor Ischemic Stroke and Risk of Major Vascular Events
Philippa C Lavallée, Hugo Charles, Gregory W Albers, et al.
Circulation. Cardiovascular Interventions
|
July 13, 2019
Central Adjudication Identified Additional and Prognostically Important Myocardial Infarctions in Patients Undergoing Percutaneous Coronary Intervention
Christoph B Olivier, Deepak L Bhatt, Sergio Leonardi, et al.
Archives of Cardiovascular Diseases
|
September 12, 2022
Immediate versus staged complete myocardial revascularization in patients with ST-segment elevation myocardial infarction and multivessel disease: A post hoc analysis of the randomized FLOWER-MI trial
Victoria Tea, Jean-François Morelle, Romain Gallet, et al.
Circulation
|
August 26, 2023
Relating Lipoprotein(a) Concentrations to Cardiovascular Event Risk After Acute Coronary Syndrome: A Comparison of 3 Tests
Michael Szarek, Esther Reijnders, J Wouter Jukema, et al.
Journal of the American College of Cardiology
|
October 4, 2005
Circulating secretory phospholipase A2 activity predicts recurrent events in patients with severe acute coronary syndromes
Ziad Mallat, Ph Gabriel Steg, Joëlle Benessiano, et al.
The Canadian Journal of Cardiology
|
June 1, 2022
Alirocumab and Cardiovascular Outcomes in Patients With Previous Myocardial Infarction: Prespecified Subanalysis From ODYSSEY OUTCOMES
Chern-En Chiang, Gregory G Schwartz, Yedid Elbez, et al.
Journal of the American Heart Association
|
December 29, 2023
Cost-Effectiveness of Icosapent Ethyl in REDUCE-IT USA: Results From Patients Randomized in the United States
William S Weintraub, Deepak L Bhatt, Zugui Zhang, et al.
JACC. Cardiovascular Interventions
|
March 23, 2013
Effect of radial versus femoral access on radiation dose and the importance of procedural volume: a substudy of the multicenter randomized RIVAL trial
Sanjit S Jolly, John Cairns, Kari Niemela, et al.
Page
of 97